Abstract

Vaccination with ChAdOx1 nCov-19 can result in the rare development of immune thrombotic thrombocytopenia mediated by platelet-activating antibodies against PF4, which clinically mimics autoimmune heparin-induced thrombocytopenia. (Funded by the German Research Foundation.).

Keywords

MedicinePlatelet factor 4ThrombosisHeparin-induced thrombocytopeniaDeep veinPulmonary embolismPlatelet activationHeparinPlateletVaccinationImmunologyInternal medicineVenous thrombosisGastroenterology

Affiliated Institutions

Related Publications

Publication Info

Year
2021
Type
article
Volume
384
Issue
22
Pages
2092-2101
Citations
2213
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

2213
OpenAlex

Cite This

Andreas Greinacher, Thomas Thiele, Theodore E. Warkentin et al. (2021). Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. New England Journal of Medicine , 384 (22) , 2092-2101. https://doi.org/10.1056/nejmoa2104840

Identifiers

DOI
10.1056/nejmoa2104840